Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Scoop Today USA journalist was involved in the writing and production of this article.
HIV Diagnostics Market Analysis: A Forward-Looking Perspective
The global HIV diagnostics market, estimated at approximately US$500 million, is on the cusp of a stable and promising growth trajectory, according to primary research findings revealed in a recent study.
Rapidly Increasing Antibody Test to Fuel Growth of HIV Diagnostics Market
Early detection of HIV is crucial to enable timely access to treatment and reduce infectiousness. The HIV diagnostics market is witnessing substantial growth, primarily driven by the increasing popularity of antibody tests. These tests detect HIV antibodies in blood or saliva, typically becoming detectable 3-12 weeks after infection. The availability of convenient at-home antibody test kits has further accelerated market expansion. The dominance of antibody testing in the market can be attributed to its effectiveness and the rising prevalence of HIV/AIDS globally.
Regional Insights
- Germany: An estimated 86,000 HIV-positive individuals reside in Germany, with around 20% of them in Berlin. The countrys high HIV incidence drives demand for diagnostics, contributing to market growth.
- United Kingdom: In 2020, there were an estimated 97,740 people living with HIV in England, and nearly 4,660 were unaware of their infection. The diagnostic services gap presents significant growth potential in the UK, with government initiatives further stimulating market expansion.
Efficacy of Treatment Properties of Antibody Testing to Drive Growth
The HIV diagnostics market encompasses three test categories: antibody testing, viral load testing, and CD4 testing. Viral load tests, used to assess a patients viral load, are the leading segment. These tests are crucial for monitoring treatment efficacy in individuals on antiretroviral therapy (ART). Modern point-of-care molecular testing has made viral load tests more accessible, further bolstering their demand.
Developed Healthcare Infrastructure to Drive North Americas Market
North America leads the global HIV diagnostics market and is expected to maintain rapid growth. Factors contributing to this include the presence of major companies, a high HIV prevalence rate, and a well-developed healthcare infrastructure. In the United States, approximately 1.2 million people are living with HIV, underscoring the demand for diagnostic tools.
In Mexico, a 55% increase in HIV-positive individuals was projected from 2018 to 2020. Initiatives like the PrEP program and investments in healthcare networks are expected to drive market expansion in the region.
Global HIV Diagnostics Market: Competitive Landscape
Key players in the HIV diagnostics market include Abbott Laboratories, Siemens AG, Merck KGaA, Hologic, Inc., Danaher Corporation, Roche Diagnostics, Thermo-Fisher Scientific Inc., Becton, Dickinson and Company, and Bio-Rad Laboratories. These companies are at the forefront of innovation and are actively contributing to the growth of the market.
Global Initiatives and Collaborations
Several global initiatives and collaborations are playing a pivotal role in expanding access to HIV diagnostics. For instance, the Afya Kamilifu project in Tanzania, funded by the Center for Disease Control and Prevention, has made HIV self-test kits available in local health facilities. Meanwhile, Roches partnership with The Global Fund aims to enhance HIV diagnosis and strengthen local capacity for prompt therapeutic interventions.
As the global HIV diagnostics market continues to evolve, it is expected to witness sustained growth driven by advancements in testing technologies, increasing awareness, and collaborative efforts to combat HIV/AIDS worldwide.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
https://www.fairfieldmarketresearch.com/report/hiv-diagnostics-market
Visit Our Blogs:
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: [email protected]
This press release first seen on Brilad
COMTEX_442320033/2840/2023-10-23T08:21:13
